DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Fallypride is an investigational drug.
There have been 14 clinical trials for Fallypride. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.
The most common disease conditions in clinical trials are Schizophrenia, Alcoholism, and Depressive Disorder, Treatment-Resistant. The leading clinical trial sponsors are Vanderbilt University Medical Center, University of California, Irvine, and Janssen-Cilag G.m.b.H.
Recent Clinical Trials for Fallypride
|Dopaminergic Dysfunction in Late-Life Depression||Columbia University||Phase 2|
|Dopaminergic Dysfunction in Late-Life Depression||Emory University||Phase 2|
|Dopaminergic Dysfunction in Late-Life Depression||Vanderbilt University Medical Center||Phase 2|